CopyPastehas never been so tasty!

Indian Pharmaceutical Industry

by anonymous

  • 0
  • 0
  • 0

The Indian Pharmaceutical Industry (IPI) is globally the 3rd largest in terms of volume and 13th largest in terms of value. The total market size of Rs. 1,233 bn includes domestic consumption market of Rs.600 bn (contributing ~48.6%) and the exports market being Rs. 633 bn (contributing ~51.4%). The industry grew at a CAGR of ~12.5% during the past five years and is expected to growth at a robust CAGR of 15.1% during FY2012-17 given huge export potential coupled with steady growth in the domestic formulation market.

Growth in the domestic pharma market will be driven by increase in the penetration of medical facilities, increase in the prevalence of chronic diseases, rising per capita income and increase in the health insurance coverage. Growth in the exports of pharmaceutical products from India will be driven by patent expiries of the major branded drugs across the world, particularly in the US market. The growth in the US market will be led by increasing generic penetration and healthy ANDA (Abbreviated New Drug Application) pipeline of Indian pharma players.

In the long term, growth in the exports market will be sustained by emerging markets like Russia, Brazil, S. Africa etc along with the enhanced focus on the niche and complex product segments such as injectables, inhalers, ophthalmics, dermatology and oral contraceptives. These are high risk - high return product segments. These offer comparatively huge entry barrier; as their clinical trials, approvals and manufacturing process are comparatively more complex and time consuming. Hence very limited number of players has entered these segments resulting in limited competition.

The report on ‘Indian Pharmaceutical Industry’ gives valuable insight on basics of the industry, domestic demand and growth drivers, exports market, imports statistics, regulatory landscape, a brief note on biopharma & crams and performance analysis of key industry players. The report also provides CARE Research’s Outlook on the domestic and exports market for the next 5 years. The report is indispensable for any company in the pharmaceutical industry, banks/ Financial Institutions (FIs), policy makers, research & academic institutions, other international and national agencies etc. Additionally, the twelve monthly updates from the date of subscription of the said report would form a potent tool for the subscribers to keep abreast with the recent developments in the industry.

Table of  Contents

Outlook and Challenges
Outlook on the Indian Pharmaceutical Industry
Outlook on the Domestic Consumption Market
Outlook on the Imports Market
Outlook on the Exports Market
Outlook on the Industry Margins
Key Challenges

Overview of Indian Pharmaceutical Industry (IPI)
Major market segments of IPI
Market size of IPI
Leading pharmaceutical companies in India
Overview of Exports Market
Emerging Markets
Industry Characteristics
Low cost advantage and skilled manpower
Exports oriented
Availability of raw materials/API market
Domestic demand and Key growth drivers
Growth in middle class population and rapid urbanization
Changing demographics and increase in per capita income
Increasing prevalence of lifestyle related diseases
Increasing health insurance penetration
Outsourcing opportunity offered by big pharma MNCs
Large generic opportunity from significant patent expiries
Pharmaceutical Exports & Imports
Regulatory Landscape
Major regulatory bodies and applicable acts, policies
Price Control
Compulsory licensing
Code of marketing practices
Key proposals of Union Budget 2012-13
Pharma R&D
Indian Pharma R&D
Global Pharma R&D
Biosimilars and biopharmaceuticals opportunity
The vaccines market
The diagnostics and therapeutics markets
CRAMS (Contract Research & Manufacturing Services) Market
SWOT Analysis
Glossary of Terms

For more information kindly visit :
Indian Pharmaceutical Industry


Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter: 
Follow us on linkedin : 
Our Blog :

Add A Comment: